Search

Lawrence, M. S., P. Stojanov, C. H. Mermel, J. T. Robinson, L. A. Garraway, T. R. Golub, M. Meyerson, S. B. Gabriel, E. S. Lander, and G. Getz. 2014. “Discovery and Saturation Analysis of Cancer Genes across 21 Tumour Types”. Nature 505: 495-501.

Lohr, J. G., V. A. Adalsteinsson, K. Cibulskis, A. D. Choudhury, M. Rosenberg, P. Cruz-Gordillo, J. M. Francis, et al. 2014. “Whole-Exome Sequencing of Circulating Tumor Cells Provides a Window into Metastatic Prostate Cancer”. Nat Biotechnol 32: 479-84.

Lohr, J. G., P. Stojanov, S. L. Carter, P. Cruz-Gordillo, M. S. Lawrence, D. Auclair, C. Sougnez, et al. 2014. “Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy”. Cancer Cell 25: 91-101.

Luo, B., H. W. Cheung, A. Subramanian, T. Sharifnia, M. Okamoto, X. Yang, G. Hinkle, et al. 2008. “Highly Parallel Identification of Essential Genes in Cancer Cells”. Proc Natl Acad Sci U S A 105: 20380-5.

Majumder, P. K., P. G. Febbo, R. Bikoff, R. Berger, Q. Xue, L. M. McMahon, J. Manola, et al. 2004. “MTOR Inhibition Reverses Akt-Dependent Prostate Intraepithelial Neoplasia through Regulation of Apoptotic and HIF-1-Dependent Pathways”. Nat Med 10: 594-601.

McGill, G. G., M. Horstmann, H. R. Widlund, J. Du, G. Motyckova, E. K. Nishimura, Y. L. Lin, et al. 2002. “Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability”. Cell 109: 707-18.

Meyers, R. M., J. G. Bryan, J. M. McFarland, B. A. Weir, A. E. Sizemore, H. Xu, N. V. Dharia, et al. 2017. “Computational Correction of Copy Number Effect Improves Specificity of CRISPR-Cas9 Essentiality Screens in Cancer Cells”. Nat Genet 49: 1779-84.

Moffett, H. F., A. N. R. Cartwright, H. J. Kim, J. Godec, J. Pyrdol, T. Aijo, G. J. Martinez, et al. 2017. “Erratum: The MicroRNA MiR-31 Inhibits CD8(+) T Cell Function in Chronic Viral Infection”. Nat Immunol 18: 1173.

Febbo, P. G., M. Lowenberg, A. R. Thorner, M. Brown, M. Loda, and T. R. Golub. 2005. “Androgen Mediated Regulation and Functional Implications of Fkbp51 Expression in Prostate Cancer”. J Urol 173: 1772-7.

Frohling, S., C. Scholl, R. L. Levine, M. Loriaux, T. J. Boggon, O. A. Bernard, R. Berger, et al. 2007. “Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles”. Cancer Cell 12: 501-13.